An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

NCT02531126 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
877
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene